280 related articles for article (PubMed ID: 18350399)
1. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma?
Pasaoglu G; Mungan D; Abadoglu O; Misirligil Z
J Asthma; 2008 Mar; 45(2):95-9. PubMed ID: 18350399
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of montelukast in the treatment of cough variant asthma.
Spector SL; Tan RA
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
[TBL] [Abstract][Full Text] [Related]
3. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors.
Chandler MH; Schuldheisz S; Phillips BA; Muse KN
Pharmacotherapy; 1997; 17(2):224-34. PubMed ID: 9085312
[TBL] [Abstract][Full Text] [Related]
4. A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma.
Athavale A; Souza GA; Avasthi R; Singh NP; Kale M; Taneja A; Sireesha K
J Indian Med Assoc; 2004 Feb; 102(2):109-11. PubMed ID: 15200214
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene receptor antagonists (Montelukast) in the treatment of asthma crisis: preliminary results of a double-blind placebo controlled randomized study.
Ferreira MB; Santos AS; Pregal AL; Michelena T; Alonso E; de Sousa AV; Pereira E; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Oct; 33(8):315-8. PubMed ID: 11763721
[TBL] [Abstract][Full Text] [Related]
6. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
7. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the leukotriene receptor antagonist montelukast therapy on asthma in childhood].
Zsigmond G; Novák Z; Kósa L
Orv Hetil; 2004 Nov; 145(48):2431-5. PubMed ID: 15638037
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
10. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B
Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
[TBL] [Abstract][Full Text] [Related]
11. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
Robinson DS; Campbell D; Barnes PJ
Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
[TBL] [Abstract][Full Text] [Related]
12. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
13. Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study).
Nieto A; Pamies R; Oliver F; Medina A; Caballero L; Mazon A
Respir Med; 2006 Jul; 100(7):1180-5. PubMed ID: 16330196
[TBL] [Abstract][Full Text] [Related]
14. Addition of montelukast versus double dose of inhaled budesonide in moderate persistent asthma.
Yildirim Z; Ozlu T; Bulbul Y; Bayram H
Respirology; 2004 Jun; 9(2):243-8. PubMed ID: 15182276
[TBL] [Abstract][Full Text] [Related]
15. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
[TBL] [Abstract][Full Text] [Related]
17. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma.
Amirav I
Isr Med Assoc J; 2008 Apr; 10(4):287-91. PubMed ID: 18548983
[TBL] [Abstract][Full Text] [Related]
18. Effects of antileukotriene among asthmatic patients.
Saenghirunvattana S
J Med Assoc Thai; 2001 May; 84(5):719-22. PubMed ID: 11560223
[TBL] [Abstract][Full Text] [Related]
19. Short-term effects of montelukast in stable patients with moderate to severe COPD.
Celik P; Sakar A; Havlucu Y; Yuksel H; Turkdogan P; Yorgancioglu A
Respir Med; 2005 Apr; 99(4):444-50. PubMed ID: 15763450
[TBL] [Abstract][Full Text] [Related]
20. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
